Filing Flows › Genpact (G) › Guidance history
Genpact (G) guidance history: what it guided and what it reported
Genpact gave guidance in 12 earnings releases on file since Feb 8, 2024. Of 2 guided periods since reported, it met or beat its own guidance twice (100%). Revenue: 2 of 2, on average +0.4% against the guided midpoint. Its releases raised guidance 8 times and lowered it 0 times.
Revenue
Met or beat 2 of 2 periods (2 above, 0 within, 0 below).
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2025 | $4.9B–$5.0B (May 7, 2025) → raised $5.0B–$5.1B (Aug 7, 2025) → raised $5.1B–$5.1B (Nov 6, 2025) | $5.1B | above the range | +0.3% |
| FY2024 | $4.6B–$4.6B (May 9, 2024) → raised $4.7B–$4.7B (Aug 8, 2024) → raised $4.7B–$4.8B (Nov 7, 2024) | $4.8B | above the range | +0.5% |
Gross margin
This line is not in the statements Filing Flows reads, so there is no reported figure to hold it to.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| Q3 2026 | 36.6% (Aug 6, 2026) | — | — | — |
| Q2 2026 | 36.4% (May 7, 2026) | — | — | — |
| Q1 2026 | 36.3% (Feb 5, 2026) | — | — | — |
| FY2026 | 36.5% (Feb 5, 2026) → reaffirmed 36.5% (May 7, 2026) → reaffirmed 36.5% (Aug 6, 2026) | — | to be reported | — |
| Q4 2025 | 36.4% (Nov 6, 2025) | — | — | — |
| Q3 2025 | 36.0% (Aug 7, 2025) | — | — | — |
| Q2 2025 | 35.5% (May 7, 2025) | — | — | — |
| Q1 2025 | 35.0% (Feb 6, 2025) | — | — | — |
| FY2025 | 36.0% (Feb 6, 2025) → reaffirmed 36.0% (May 7, 2025) → reaffirmed 36.0% (Aug 7, 2025) → reaffirmed 36.0% (Nov 6, 2025) | — | — | — |
| Q4 2024 | 35.6% (Nov 7, 2024) | — | — | — |
Adjusted EPS
The guide is on an adjusted basis that the GAAP statements do not show, so there is no reported figure to hold it to.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| Q3 2026 | $5.00 (Aug 6, 2026) | — | — | — |
| Q2 2026 | $5.00 (May 7, 2026) | — | — | — |
| Q1 2026 | $6.00 (Feb 5, 2026) | — | — | — |
| FY2026 | $6.00 (Feb 5, 2026) → lowered $5.00 (Aug 6, 2026) → reaffirmed $5.00 (Nov 5, 2026) | — | to be reported | — |
| Q4 2025 | $6.00 (Nov 6, 2025) | — | — | — |
| Q3 2025 | $6.00 (Aug 7, 2025) | — | — | — |
| Q2 2025 | $5.00 (May 7, 2025) | — | — | — |
| Q1 2025 | $10.00 (Feb 6, 2025) | — | — | — |
| FY2025 | $10.00 (Feb 6, 2025) → lowered $5.00 (May 7, 2025) → raised $6.00 (Aug 7, 2025) → reaffirmed $6.00 (Nov 6, 2025) | — | — | — |
| FY2024 | $11.00 (Feb 8, 2024) → lowered $9.00 (May 9, 2024) → lowered $7.00 (Aug 8, 2024) → lowered $6.00 (Nov 7, 2024) | — | — | — |
The latest quarter
Genpact, Q3 2026: revenue $1.4B (+7% year over year), operating margin 15.2%, net earnings $152M, operating cash flow $93.1M. The chart follows the revenue to costs, profit and cash.
Questions
Does Genpact beat its guidance?
Genpact gave guidance in 12 earnings releases on file since Feb 8, 2024. Of 2 guided periods since reported, it met or beat its own guidance twice (100%). Revenue: 2 of 2, on average +0.4% against the guided midpoint.
How often does Genpact raise guidance?
Its earnings releases raised guidance 8 times and lowered it 0 times since Feb 8, 2024.
Each guided period is held to the last guidance given before its figures were reported; a single figure counts as in line within 1% (0.25 pts for a rate). Reported figures are GAAP, from the company's filings; adjusted guidance shows its moves only.